InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
4.450
-0.600 (-11.88%)
Jan 22, 2025, 10:35 AM EST - Market open
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$381,577
Profits / Employee
-$524,353
Market Cap
3.20M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
INM News
- 3 hours ago - InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds - Newsfile Corp
- 1 day ago - InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study - Newsfile Corp
- 4 weeks ago - InMed Announces Results of 2024 Annual General Meeting - Newsfile Corp
- 5 weeks ago - InMed Enters Into Standby Equity Purchase Agreement - Newsfile Corp
- 2 months ago - InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System - Newsfile Corp
- 2 months ago - InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile Corp
- 2 months ago - InMed Announces Share Consolidation to Satisfy Nasdaq Listing Rules - Newsfile Corp
- 2 months ago - InMed Pharmaceuticals Announces Decision by NASDAQ Hearings Panel to Grant Exception to Implement Share Consolidation to Satisfy NASDAQ Listing Rules - Newsfile Corp